Procept Biorobotics Corporation (PRCT) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Procept Biorobotics Corporation  (NASDAQ: PRCT)


Procept Biorobotics's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Procept Biorobotics's ROI in the second quarter of 2026?
Procept Biorobotics Corporation recorded a cumulative net loss of $-110 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -25.25%.

Within the Healthcare sector 268 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3290 to 3333.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 3.62 % 17.69 % 33.94 % 47.94 % 25.96 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 415 423 442 458 463
Return On Investment (TTM) -25.25 % -22.94 % -20.88 % -18.36 % -20.06 %
PRCT's Overall Ranking # 3333 # 3290 # 2440 # 2900 # 2915
Seq. Investment Change TTM -2.7 % -2.4 % -0.64 % 9.81 % 10.52 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -110 -102 -96 -85 -84

PRCT Company Profile >> Back to PRCT Roi Comparisons >> See Annual PRCT Return On Investment



Return On Investment PRCT's Ranking
Within: No.
Industry # 84
Sector # 269
Overall # 3333

Return On Investment Statistics
High Average Low
267.16 %
-5.39 %
-38.5 %
(Dec 31 2021)   (Jun 30 2023)







Financial Statements
Procept Biorobotics's II. Quarter Investments $ 415 Millions PRCT's Balance sheet
Procept Biorobotics's II. Quarter Income $ -27 Millions Quarterly PRCT's Income Statement
PRCT's Income by Division See PRCT's Income by Division


PRCT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 418 454 333 250 319
Y / Y Investment Growth -8.01 % 36.5 % 33.01 % -21.56 % -
Net Income in Millions -96 -91 -106 -87 -60
Y / Y Net Income Growth - - - - -
Annual Return On Investment -22.88 % -20.13 % -31.84 % -34.85 % -18.77 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PRCT's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PRCT's Competitors
Subscribers only: Roi for Procept Biorobotics's Suppliers
Subscribers only: Return On Investment for PRCT's Customers

Other Ratios
PRCT's Roa PRCT's Inventory Turnover Ratio PRCT's Growth Rates PRCT's Dividend Statistics
PRCT's Profitability Ratios PRCT's Asset Turnover Ratio PRCT's Dividend Growth
PRCT's Roe PRCT's Valuation Ratios PRCT's Financial Strength Ratios PRCT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-09T00:14:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.